Meeting
2021 ASCO Quality Care Symposium
Association between insurance plan, prior authorization, and time to receipt of oral anticancer drugs.
Authors
Morgan RL Lichtenstein
Columbia University Medical Center, New York, NY
Morgan RL Lichtenstein, Melissa Parsons Beauchemin, Rohit R. Raghunathan, Sahil D Doshi, Cynthia Law, Melissa Kate Accordino, Elena B. Elkin, Jason Dennis Wright, Dawn L. Hershman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cost, Value, and Policy; Health Equity and Disparities; Patient Experience
Track
Cost, Value, and Policy,Technology and Innovation in Quality of Care,Health Care Access, Equity, and Disparities,Patient Experience,Quality, Safety, and Implementation Science
Sub Track
Organizational and Operational Issues
Citation
J Clin Oncol 39, 2021 (suppl 28; abstr 6)
DOI
10.1200/JCO.2020.39.28_suppl.6
Abstract #
6
Poster Bd #
A1
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Quality Care Symposium
Medicare Part D spending for the 10 costliest oral anticancer drugs.
First Author: Kaitlyn McBride
Poster
2014 Palliative and Supportive Care in Oncology Symposium
Oral oncolytics: Patient-monitoring improvements in private practice.
First Author: Tallat Mahmood
Poster
2022 ASCO Quality Care Symposium
Creation of standard work for the management of outpatient oral antineoplastic therapy.
First Author: Junid Naveed Naveed Ahmad
Poster
2022 ASCO Quality Care Symposium
Total cost of care of hematologic malignancy episodes versus target price under the Oncology Care Model.
First Author: Jennifer Nguyen